HomeHealth Care

Health Care

RxSight Announces Preliminary Q2 Results

Yuika Yoshida - July 7, 2026

Health Care

Judge Upholds $382M Applied Medical Verdict Win

Yuika Yoshida - July 6, 2026

Health Care

Cellese Taps Christopher Hausman as CEO

Yuika Yoshida - July 6, 2026

Health Care

UCI Names Stamos Interim Health Affairs VC

Yuika Yoshida - July 6, 2026

Health Care

CalOptima Awards $3.6M to Seven Organizations

Yuika Yoshida - July 1, 2026

Health Care

MDxHealth Study Backs Prostate Cancer Test

Yuika Yoshida - June 29, 2026

Health Care

Beckman Coulter Defines OC as Hub of MedTech Companies

Emily Santiago-Molina - June 29, 2026

Health Care

Edwards Lifesciences: The Heart of OC Medtech

Yuika Yoshida - June 29, 2026

Health Care

Sensible Care Expands Behavioral Health Network

Yuika Yoshida - June 29, 2026

Health Care

Edwards Lifesciences Reports New Clinical Trial Updates

Yuika Yoshida - June 26, 2026

Health Care

Glaukos Moves Into Demodex Blepharitis Space

Yuika Yoshida - June 25, 2026

Health Care

Eledon Teams Up With Natera on Phase 3 Study

Yuika Yoshida - June 25, 2026

Health Care

ASP Acquires Majority Share in UV Smart

Yuika Yoshida - June 24, 2026

Health Care

Ramin Mousavi Appointed Chairman of CardioMech

Yuika Yoshida - June 24, 2026

Health Care

UCI Names New Interim Vice Chancellor of Health Affairs

Yuika Yoshida - June 23, 2026

Health Care

FDA Clears New Masimo Monitoring Feature

Yuika Yoshida - June 23, 2026

Health Care

Danaher Finalizes $9.9B Purchase of Masimo

Yuika Yoshida - June 22, 2026

Health Care

Ensign Group Faces Short Sellers Scrutiny

Yuika Yoshida - June 22, 2026

Health Care

Octane Launches Mussallem Cardiovascular Accelerator

Yuika Yoshida - June 18, 2026

Health Care

Katie Szyman Steps Down from Masimo

Yuika Yoshida - June 16, 2026

Health Care

Cellese Names New CEO

Yuika Yoshida - June 16, 2026

Health Care

Allergan’s Skinvive Gets FDA Approval for Additional Use

Yuika Yoshida - June 16, 2026

Health Care

Wave Neuroscience Says PTSD System Cleared by FDA

Anastasia Efremova - June 15, 2026

Health Care

PreludeDx Nears $40M with New Breast Cancer Test

Yuika Yoshida - June 15, 2026

Health Care

SpyGlass Taps Shannon Treviño as General Counsel

Yuika Yoshida - June 15, 2026

Health Care

Veritas Secures $12M for Aortic Disease Treatment

Yuika Yoshida - June 15, 2026

Health Care

Former First Lady Jill Biden Joins Willow Board

Yuika Yoshida - June 12, 2026

Health Care

Danaher Closes on Acquisition of Masimo

Yuika Yoshida - June 10, 2026

Health Care

CalOptima Invests $430M to Boost Provider Reimbursement

Yuika Yoshida - June 10, 2026

Health Care

New Study Highlights Ambry Genetics RNA Testing

Yuika Yoshida - June 9, 2026

Subscribe Here

Health Care

RxSight Announces Preliminary Q2 Results

Judge Upholds $382M Applied Medical Verdict Win

Cellese Taps Christopher Hausman as CEO

UCI Names Stamos Interim Health Affairs VC

CalOptima Awards $3.6M to Seven Organizations

MDxHealth Study Backs Prostate Cancer Test

Beckman Coulter Defines OC as Hub of MedTech Companies

Edwards Lifesciences: The Heart of OC Medtech

Sensible Care Expands Behavioral Health Network

Edwards Lifesciences Reports New Clinical Trial Updates

Glaukos Moves Into Demodex Blepharitis Space

Eledon Teams Up With Natera on Phase 3 Study

ASP Acquires Majority Share in UV Smart

Ramin Mousavi Appointed Chairman of CardioMech

UCI Names New Interim Vice Chancellor of Health Affairs

FDA Clears New Masimo Monitoring Feature

Danaher Finalizes $9.9B Purchase of Masimo

Ensign Group Faces Short Sellers Scrutiny

Octane Launches Mussallem Cardiovascular Accelerator

Katie Szyman Steps Down from Masimo

Cellese Names New CEO

Allergan’s Skinvive Gets FDA Approval for Additional Use

Wave Neuroscience Says PTSD System Cleared by FDA

PreludeDx Nears $40M with New Breast Cancer Test

SpyGlass Taps Shannon Treviño as General Counsel

Veritas Secures $12M for Aortic Disease Treatment

Former First Lady Jill Biden Joins Willow Board

Danaher Closes on Acquisition of Masimo

CalOptima Invests $430M to Boost Provider Reimbursement

New Study Highlights Ambry Genetics RNA Testing

Advertise With Us

About Us

Subscriber Links

Other Journals